JVMCX | MCVAX | JVMCX / MCVAX | |
Total Expense Ratio | 1.87 | 1.19 | 157% |
Annual Report Gross Expense Ratio | 1.88 | 1.19 | 158% |
Fund Existence | 14 years | 11 years | - |
Gain YTD | -1.344 | 0.284 | -473% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 1000 | 1000 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 20.9B | 968M | 2,159% |
Annual Yield % from dividends | 0.00 | 1.11 | - |
Returns for 1 year | -9.20 | -5.08 | 181% |
Returns for 3 years | 2.61 | -7.41 | -35% |
Returns for 5 years | 60.23 | 29.15 | 207% |
Returns for 10 years | 20.37 | -3.10 | -656% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
TARK | 34.74 | 3.65 | +11.74% |
Tradr 2X Long Innovation ETF | |||
DFLV | 30.32 | 0.78 | +2.64% |
Dimensional US Large Cap Value ETF | |||
PMAR | 40.87 | 0.72 | +1.79% |
Innovator U.S. Equity Power BffrETF™-Mar | |||
HCOM | 15.51 | N/A | N/A |
Hartford Schroders Commodity Strtgy ETF | |||
DMB | 10.25 | -0.07 | -0.68% |
BNY Mellon Municipal |